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Supplementary Figure 1: UGDH mutations affect highly conserved residues. (a) Pedigrees of 
families F20 to F25 from Saudi Arabia segregating autosomal recessive developmental epileptic 
encephalopathy. Filled black symbols, affected individuals. Crossed symbols, deceased individual. 
Mutations in UGDH protein are presented below pedigrees. Homozygous mutations are presented 
in bold (m in the pedigrees). Healthy siblings that could be sequenced are either homozygous WT 
(F25-II:1 and II:2) or heterozygous (F25-II:3) for the p.Arg317Gln mutation. (b) UGDH proteins 
alignment (using the CLUSTAL OMEGA software1,2) shows the conservation of the 22 affected 
amino acids found in 26 patients. The conservation of the mutated residues is shown in red 
(missense) and black (nonsense). Mutations found in a homozygous state are shown in bold. 
NAD-binding (blue), UDP-binding (orange) and central (pink) domains are highlighted. The 
secondary structure of UGDH is presented above the alignment as β-sheets (red arrows) and α-
helices (green spirals). 
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Supplementary Figure 2: Mutations in UGDH enzyme possibly alter its oligomerization. 
Front (a) and side (b) views of the ribbon diagram of the UGDH hexamer bound to UDP-Glc and 
NADH. (c-d) Two close-up views of the ribbon diagrams of the UGDH protein bound to UDP-Glc 
and NADH as a monomer (d, subunit A; subunits C and E are shown at their interface with subunit 
A) and a dimer (e, subunits A and B). Residues carrying missense mutations in the patients are 
highlighted as 3D backbone. Residues Q110 and T325 known to interact together for dimer 
formation3; and residue V132 (important for hexamerization3) are highlighted in black backbone. 
Inserts 2b, 2c and 2d correspond to the close-up views shown in Figure 2b, c and d, respectively. 
In all the structures, NAD-binding (blue), central (light/dark pink), and UDP-binding (orange) 
domains are shown. UDP-Glc (dark red) and NADH (midnight blue) are represented as colored 
carbon backbones. Adapted from PDB code 2Q3E4 using the Swiss-Pdb Viewer software5. 
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Supplementary Figure 3: Mutant ugdhI331D/I331D zebrafish larvae are not more susceptible to 
seizures. (a) qPCR analysis for endogenous c-fos expression in the heads of 7-dpf (days post 
fertilisation) old larvae incubated with increasing PTZ concentration (from 0 to 15 mM as indicated 
below the x axis). n biological replicates of 20 heads each is indicated above the graph. (b-d) 
Locomotion assay in 7-dpf old larvae without (n= 42 wt, n= 48 heterozygous, and n= 36 
homozygous larvae) or with PTZ 15 mM (n= 48, n= 48, and n= 42, respectively). Plotted are (b) the 
percentage of time that larvae spent moving, (c) the percentage of time spent at high speed, and 
(d) their total distance travelled in a user-defined area during a total recorded time of 6 minutes. (a-
d) Data are mean ±s.e.m. NS, not significant, *P<0.05, **P<0.01, ***P<0.001, one-way ANOVA 
with Bonferroni’s correction. (e) Dorsal and lateral views of control and homozygous larvae at 7-dpf 
showing wild type, mild (slight pericardial edema, non-inflated swim bladder), and severe 
(extensive pericardial edema, non-inflated swim bladder) phenotypes. The proportion of each 
observed phenotype from ugdhwt/i331d incrosses is indicated below the pictures as percentage. Data 
are mean ±s.e.m from n = 10 incrosses with a total of 1877 larvae. Pericardial edema (black 
arrow), inflated swim bladder (white arrow head), and non-inflated swim bladder (black arrow 
heads) are indicated. Scale bar: 100 µm (a-e) Abbreviations: wt: ugdhwt/wt wild type larvae, het: 
ugdhwt/i331d heterozygous larvae and hom: ugdhi331d/i331d homozygous larvae. For graphs source 
data, please refer to the source data file 2. 
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Supplementary Figure 4: Patient-derived cerebral organoids are underdeveloped while 
isolated neurons have normal activity (relative to Fig. 4). (a) Volumes of cerebral organoids 
derived from iPSCs from WT, unaffected parent (UGDH WT/A82T), and patients (UGDH 
A82T/A82T, Y14C/S72P, and R65*/Y367C) after 10 weeks of differentiation from 3 independent 
batches (as indicated). Volumes of cerebral organoids in PBS (left panel, batches 2 and 3) and in 
paraffin (right panel, batches 1 and 2) are shown. The iPSCs clone number used to derive the 
cerebral organoids (c), and the number of cerebral organoids analyzed (n) are indicated. Mean ± 
SD is plotted. The data presenting in Fig. 4a are also included. (b) RT-qPCR analysis for neuronal 
differentiation markers (PAX6, TBR2 and TUJ1) in cerebral organoids derived from iPSCs from WT 
(n= 4 cerebral organoids), unaffected parent (WT/A82T, n= 4), and patients (A82T/A82T (n= 4), 
Y14C/S72P (n= 3), and R65*/Y367C (n= 7). Data are mean ± SD fold change relative to WT, and 
normalized to GAPDH. The iPSCs clone numbers used to derive the cerebral organoids (c), and 
the 2 independent batches of cerebral organoids are indicated. The data from batch 2 are also 
reported in Fig. 4c. (c) Representative images of consecutive sections of cerebral organoids 
derived from clone 2 iPSCs from WT, and patients (A82T/A82T, Y14C/S72P, and R65*/Y367C) 
stained with H&E, and immunostained with markers TUJ1/PCNA/DAPI, SOX2/PCNA/DAPI. Scale 
bar = 100 μm. (d) Graphical representation of the number of neuron-evoked spikes and mean 
firing rate detected by multi-electrode arrays (n= 6 per line per time-point) of NPCs-derived 
neurons. Mean ± SD is plotted. (a, b, d) Asterisks indicate p-values of p<0.05(*), p<0.01(**), 
p<0.001(***), NS: non-significant (p>0.05) as determined by ANOVA test with Bonferroni correction 
(a, c) or with Tukey’s multiple correction (d). For graphs source data, please refer to the source 
data file 2. 
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4 39523002 39523002 G A hom 
UGDH : NM_003359 ;  
exon2 : c.131C>T ; p.A44V 
1.65E-05 0.01 0.871 33 6.07 9.434 segregates 
1 230824270 230824270 G T hom 
COG2 : NM_007357 ;  
exon15 : c.1756G>T ; p.A586S 
. 0.07 1 32 5.67 9.071 does not segregate 
19 1036553 1036553 G T hom 
CNN2 : NM_004368 ;  
exon6 : c.646G>T ; p.A216S 
. 0.03 0.994 19.7 4.04 9.34 does not segregate 
22 30500401 30500401 G A hom 
HORMAD2 : NM_001329457 ;  
exon6 : c.269G>A ; p.C90Y 
9.95E-05 0.01 1 18.35 5.19 3.859 does not segregate 
1 229600595 229600595 G A hom 
NUP133 : NM_018230 ;  
exon18 : c.2327C>T ; p.T776M 
3.30E-05 0.12 0.96 17.32 5.27 5.412 does not segregate 
1 231396281 231396281 A G hom 
GNPAT : NM_014236 ;  
exon3 : c.290A>G ; p.D97G 
. 0.08 0.653 17.15 4.83 7.192 does not segregate 
1 215793416 215793416 A G hom 
KCTD3 : NM_016121 ;  
exon18 : c.1904A>G ; p.H635R 
8.62E-06 0.46 0 12.3 5.77 3.253 does not segregate 
 
Supplementary Table 1: Variant list after filtering for homozygous or compound heterozygous variants in exomes from patient 
F1-II:3 and F1-II:6. Annotations were obtained using ANNOVAR6. CADD scores are PHRED-scaled. Abbreviations: Chr.: chromosome; 
“.”: variant not found in ExAC7; Ref: reference; Alt: alternative; ND: not determined; hom: homozygous.  
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F7 4 39505523 39505523 T C c.1346A>G;p.H449R . . . 0.78 0.006 15.11 5.62 7.961 -1.05 
F12, F14, F15 4 39505541 39505541 C T c.1328G>A;p.R443H . . . 0.03 0.999 35 5.62 7.741 -1.28 
F15 4 39505545 39505545 G A c.1324C>T;p.R442W . . 4.06E-06 0 1 23.7 4.78 4.839 -0.856 
F3 4 39506072 39506072 C A c.1228G>T;p.A410S . 1.66E-05 8.12E-06 0 0.999 28.2 4.78 7.411 -2.4 
F3 4 39506123 39506123 G A c.1177C>T;p.R393W . 8.94E-06 1.63E-05 0 0.993 20.5 4.75 3.811 -0.5 
F6 4 39506928 39506928 T C c.1100A>G;p.Y367C . . . 0 1 23.2 6.03 7.425 -1.8 
F8 4 39506960 39506960 A C c.1068T>G;p.Y356* . . . 0.15 n/a 36 -0.679 0.404 n/a 
F16-F25 4 39507325 39507325 C T c.950G>A;p.R317Q . 5.77E-05 4.89E-05 0.02 0.982 20.9 4.87 4.688 -1.23 
F2 4 39507359 39507359 T C c.916A>G;p.M306V . . . 0.64 0.193 15.01 5.07 7.698 -1.13 
F12 4 39507368 39507368 C T c.907G>A;p.V303I . . . 0.02 0.961 23.1 4.98 7.487 -1.07 
F10 4 39511380 39511380 C G c.811G>C;p.G271R . . . 0 1 29.9 5.51 7.167 -0.42 
F10 4 39511427 39511427 A G c.764T>C;p.I255T . . 8.15E-06 0 0.999 23.4 5.51 8.569 -3.21 
F11 4 39511985 39511985 C G c.651G>C;p.E217D . . . 0 1 18.34 1.39 0.564 -2.31 
F9 4 39512113 39512113 G C c.523C>G;p.P175A . . . 0.08 0.997 21.7 5.12 9.196 -1.64 
F2, F7 4 39512283 39512283 G A c.463C>T;p.Q155* . . 4.06E-06 0.14 n/a 36 5.12 9.137 n/a 
F14 4 39512399 39512399 A G c.374T>C;p.I116T . . . 0 0.998 26.1 5.95 8.642 -3.24 
F5 4 39515723 39515723 C T c.244G>A;p.A82T . . . 0.03 0.999 23.4 3.93 6.915 -1.83 
F4 4 39515753 39515753 A C c.214T>G;p.S72A . . . 0 0.949 28.8 5.66 8.263 -0.35 
F6, F13 4 39515774 39515774 G A c.193C>T;p.R65* . 9.96E-05 7.43E-05 1 n/a 24.6 1.78 2.743 n/a 
F1, F11, F13 4 39523002 39523002 G A c.131C>T;p.A44V . 1.65E-05 2.05E-05 0.01 0.871 33 6.07 9.434 -0.27 
F8 4 39523008 39523008 A G c.125T>C;p.I42T . . . 0 0.999 26.5 6.07 8.923 -2.76 
F9 4 39523063 39523063 C T c.70G>A;p.A24T . . . 0 1 36 6.07 7.456 -2.07 
F4 4 39523092 39523092 T C c.41A>G;p.Y14C 7.70E-05 8.24E-06 4.10E-06 0 1 26.8 6.07 7.665 -0.18 
 
Supplementary Table 2: Genetic characteristics of identified UGDH mutations and their predicted effect on the protein stability. 
Families carrying homozygous mutations are depicted in bold. All cDNA positions refer to transcript NM_003359. Annotations were 
obtained using ANNOVAR6. CADD scores are PHRED-scaled. ∆∆G is the predicted stability change expressed as variation in Gibbs Free 
Energy (Kcal mol-1) with negative values denoting destabilizing mutations, as determined by DUET software8. Abbreviations: Chr: 
chromosome; “.”: variant not found in database; Ref: reference; Alt: alternative; n/a: not applicable. 
 
















4 39501722 CAAA C c.*38_*40delTTT 2319 4.38E-01 . . . . . 3' UTR variant  
4 39501722 CAA C c.*39_*40delTT 111 1.27E-01 . . . . . 3' UTR variant  
4 39501722 CA C c.*40delT 37 9.19E-02 . . . . . 3' UTR variant  
4 39501722 CAAAA C c.*37_*40delTTTT 8 1.35E-01 . . . . . 3' UTR variant  
4 39528752 G A c.-8+151C>T 2907 7.30E-01 . . . . . intronic variant 
4 39511359 T C c.811+21A>G 2685 1.73E-01 . . . . . intronic variant 
4 39510175 G A c.906+11C>T 2659 1.72E-01 . . . . . intronic variant 
4 39515655 T C c.264+48A>G 2391 1.67E-01 . . . . . intronic variant 
4 39510329 C T c.812-49G>A 1350 1.43E-01 . . . . . intronic variant 
4 39506144 C T c.1172-16G>A 1047 1.06E-01 . . . . . intronic variant 
4 39515853 T C c.163-49A>G 51 2.33E-02 . . . . . intronic variant 
4 39506997 G GA c.1038-8dupT 4 8.69E-03 . . . . . intronic variant 
4 39505456 C G c.1374+39G>C 1 2.01E-05 . . . . . intronic variant 
4 39505643 C T c.1264-38G>A 1 2.97E-04 . . . . . intronic variant 
4 39507206 A C c.1037+32T>G 1 4.40E-04 . . . . . intronic variant 
4 39506052 C G c.1248G>C;p.E416D 1 1.21E-03 0.05 0.511 13.66 1.48 0.594 Missense variant. Prediction scores and MAF are not suggestive for a disease causing variant 
4 39506938 G C c.1090C>G;p.L364V 1 2.23E-04 0.63 0.062 14.31 6.03 7.293 Missense variant. Prediction scores and MAF are not suggestive for a disease causing variant 
4 39506997 GA G c.1038-8delT 2624 2.20E-01 . . . . . Variant in splice region. No effect on the splicing product is predicted by HSF 
4 39511530 T TA c.664-4dupT 1022 3.19E-01 . . . . . Variant in splice region. No effect on the splicing product is predicted by HSF 
4 39510283 G A c.812-3C>T 6 2.97E-03 . . . . . Variant in splice region. No effect on the splicing product is predicted by HSF 
4 39511530 TA T c.664-4delT 2 4.90E-02 . . . . . Variant in splice region. No effect on the splicing product is predicted by HSF 
4 39511530 T TAA c.664-5_664-4dupTT 1 7.86E-03 . . . . . Variant in splice region. No effect on the splicing product is predicted by HSF 
4 39510264 A G c.828T>C;p.c276c 2689 1.72E-01 . . . . . synonymous variant  
4 39515736 A G c.231T>C;p.D77D 2548 1.69E-01 . . . . . synonymous variant  
4 39512347 T C c.399A>G;p.P133P 963 1.15E-01 . . . . . synonymous variant  
4 39522995 A G c.138T>C;p.N46N 6 2.99E-03 . . . . . synonymous variant  
4 39523001 C A c.132G>T;p.A44A 1 5.69E-04 . . . . . synonymous variant  
 
Supplementary Table 3: Homozygous UGDH variants in ExAC: A total of 27 homozygous variants were recorded in ExAC. Twenty of 
these variants are synonymous, intronic or in the UTR regions. Five variants are within splice site regions but do not affect the splicing 
products according to the Human Splicing Finder9. Only two homozygous missense variants were found, each of them in one single case. 
Both have low pathogenicity prediction scores than the patients’ mutations reported here. No homozygous truncating mutations were 
present in ExAC. 
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Species Gene Forward Primer  5' - 3' Reverse Primer 5' - 3' purpose 
Human UGDH CTTGCCCAGAGAATAAGCAG CAAATTCAGAACATCCTTTTGGA qPCR 
Human β-ACTIN ATGTTTGAGACCTTCACACC AGGTAGTCAGTCAGGTCCCGGCC qPCR 
Human GAPDH TGAACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG qPCR 
Human PAX6 CCGTGTGCCTCAACCGTA CACGGTTTACTGGGTCTGG qPCR 
Human TBR2 AAATGGGTGACCTGTGGCAAAGC CTCCTGTCTCATCCAGTGGGAA qPCR 
Human TUJ1 TCAGCGTCTACTACAACGAGGC GCCTGAAGAGATGTCCAAAGGC qPCR 
zebrafish PCR1 GTATGTGCAGGTGATTGACA TGTAGGTCACAGGTTTTTGACA genotyping 
zebrafish PCR2 GACATGAATGAATATCAGAGAAAGAG AGGAGAAACCCAACAACGC genotyping 
zebrafish c-fos AACTGTCACGGCGATCTCTT GCAGGCATGTATGGTTCAGA qPCR 
zebrafish gapdh GTGGAGTCTACTGGTGTCTT GTGCAGGAGGCATTGCTTAC qPCR 
 




Protein Organism Dilution factor Reference 
UGDH rabbit 500 Sigma-Aldrich, USA, HPA036657 
GAPDH mouse 2000 Santa Cruz Biotechnology Inc., SC 47724 
SOX2 mouse 200 R&D systems, MAB2018 
TUJ1 mouse 3000 Biolegend MMS-435P 
GFAP rabbit 2500 Dako Z0334 
PCNA rabbit 1µg/ml abcam ab18197 
 
Supplementary Table 5: List of antibodies 
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Prevalence estimation of affected UGDH patients based on gnomAD7. 
 
In a simplified model, the assumption was made that UGDH mutations are spread equally in 
general population reflecting the worldwide distribution of families in our series. The model ignores 
the fact that several mutations were found in families with consanguineous background (F1, F5, 
F16-F25) and therefore likely underestimates the number of affected patients. Based on the 19 
detected mutations and the gnomAD7 spanning 123,136 exomes the allele frequency of identified 
mutations was assessed. Allele frequencies were available for eight mutations, the other eleven 
mutations were not represented in gnomAD7 and are therefore underrepresented in this estimation. 
Allele frequencies of these eight mutations added up to 1.84 x 10-4 (Suppl. Table 2). Further, we 
assumed that all Loss-of-Function (LoF) variants are pathogenic but hypothesized that biallelic LoF 
variants are not viable. In gnomAD7, additional 15 LoF variants were found with a total allele 
frequency of 8.32 x 10-5 (Suppl. Table 6). Additional potentially pathogenic variants were identified 
by filtering missense variants from gnomAD7 with the following strict filter criteria: 
 
I) minor allele frequency (MAF) below 1 x 10-4 (rendering the range of already detected 
pathogenic variants) 
II) affecting a residue with similar or higher conservation scores than in the detected 
mutations (phylop100way>4)  
III) consistently pathogenic predictions by SIFT10, PolyPhen-2 HDIV11, LRT12 and 
MutationTaster13.  
 
These strict filter criteria resulted in 50 additional potentially pathogenic missense variants with an 
allele frequency of 4.06 x 10-4 (Suppl. Table 7). Based on these results, the allele frequency of 
UGDH mutations in global population is calculated to be around 6.73 x 10-4, which would lead to a 
prevalence of 1:2,210,000 (Suppl. Table 8). However, without confirming the potentially 
pathogenic missense variants identified in gnomAD7 and just taking into account LoF variants and 









Chr. Start End Ref Alt Variant MAF in GnomAD 
4 39501837 39501841 TTCTC - exon12 : c.1407_1411del ; p.K469fs 4.09E-06 
4 39506054 39506054 C A exon10 : c.1246G>T ; p.E416* 4.06E-06 
4 39506871 39506871 G T exon9 : c.1157C>A ; p.S386* 8.68E-06 
4 39506971 39506971 - A exon9 : c.1056dupT ; p.I353fs 4.48E-06 
4 39507261 39507261 G - exon8 : c.1014delC ; p.F338fs 4.11E-06 
4 39510254 39510254 C - exon7 : c.838delG ; p.D280fs 4.29E-06 
4 39511477 39511477 A - exon6 : c.714delT ; p.S238fs 4.08E-06 
4 39511989 39511989 G T exon5 : c.647C>A ; p.S216* 4.06E-06 
4 39512105 39512108 TCTG - exon5 : c.528_531del ; p.D176fs 4.06E-06 
4 39512140 39512140 C A exon5 : c.496G>T ; p.G166* 4.06E-06 
4 39512316 39512316 - TCTCT exon4 : c.429_430insAGAGA ; p.F144fs 4.06E-06 
4 39512427 39512427 T A exon4 : c.319A>T ; p.K107* 2.44E-05 
4 39515800 39515800 C - exon3 : c.167delG ; p.G56fs 4.73E-06 
4 39523091 39523092 AT - exon2 : c.41_42del ; p.Y14fs 4.08E-06 
          Total=  8.32E-05 
 
Supplementary Table 6: Frequency of additional LoF Variants from gnomAD. Abbreviations: Chr = chromosome, Ref = reference, 
Alt = alternative; n/a: not applicable. All cDNA positions refer to transcript NM_003359. Annotations were obtained using ANNOVAR6. 
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4 39512065 39512065 C A exon5 : c.571G>T ; p.A191S 5.28E-05 D D D D 7.266 
4 39515773 39515773 C T exon3 : c.194G>A ; p.R65Q 3.72E-05 D D D D 6.915 
4 39501809 39501809 G A exon12 : c.1439C>T ; p.P480L 2.85E-05 D D D D 8.27 
4 39512160 39512160 T C exon5 : c.476A>G ; p.N159S 2.03E-05 D D D D 7.424 
4 39501852 39501852 C T exon12 : c.1396G>A ; p.V466M 1.67E-05 D P D D 4.082 
4 39505590 39505590 G A exon11 : c.1279C>T ; p.R427C 1.22E-05 D D D D 4.851 
4 39512097 39512097 A G exon5 : c.539T>C ; p.I180T 1.22E-05 D D D D 8.697 
4 39515753 39515753 A G exon3 : c.214T>C ; p.S72P 9.80E-06 D D D D 8.263 
4 39515786 39515786 C T exon3 : c.181G>A ; p.V61I 9.34E-06 D P D D 6.915 
4 39515720 39515720 C T exon3 : c.247G>A ; p.D83N 8.89E-06 D P D D 6.915 
4 39506944 39506944 C T exon9 : c.1084G>A ; p.A362T 8.63E-06 D D D D 5.507 
4 39522985 39522985 G C exon2 : c.148C>G ; p.L50V 8.25E-06 D P D D 9.434 
4 39511427 39511427 A G exon6 : c.764T>C ; p.I255T 8.15E-06 D D D D 8.569 
4 39506117 39506117 C T exon10 : c.1183G>A ; p.V395M 8.14E-06 D D D D 7.411 
4 39505551 39505551 C T exon11 : c.1318G>A ; p.D440N 8.12E-06 D D D D 7.741 
4 39506072 39506072 C A exon10 : c.1228G>T ; p.A410S 8.12E-06 D D D D 7.411 
4 39512092 39512092 C T exon5 : c.544G>A ; p.G182R 8.12E-06 D D D D 7.266 
4 39512348 39512348 G A exon4 : c.398C>T ; p.P133L 8.12E-06 D D D D 9.137 
4 39515749 39515749 G C exon3 : c.218C>G ; p.T73S 4.69E-06 D P D D 6.941 
4 39515720 39515720 C G exon3 : c.247G>C ; p.D83H 4.44E-06 D D D D 6.915 
4 39511385 39511385 C T exon6 : c.806G>A ; p.S269N 4.33E-06 D D D D 7.167 
4 39523114 39523114 T A exon2 : c.19A>T ; p.I7F 4.26E-06 D D D D 5.924 
4 39523114 39523114 T G exon2 : c.19A>C ; p.I7L 4.26E-06 D P D D 5.924 
4 39501776 39501776 T C exon12 : c.1472A>G ; p.K491R 4.17E-06 D P D D 6.941 
4 39506919 39506919 T G exon9 : c.1109A>C ; p.K370T 4.16E-06 D D D D 7.425 
4 39507272 39507272 C T exon8 : c.1003G>A ; p.G335R 4.11E-06 D D D D 7.487 
4 39501786 39501786 G A exon12 : c.1462C>T ; p.P488S 4.10E-06 D D D D 8.525 
4 39511473 39511473 G T exon6 : c.718C>A ; p.L240M 4.08E-06 D D D D 4.278 
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4 39523074 39523074 C T exon2 : c.59G>A ; p.C20Y 4.08E-06 D D D D 7.456 
4 39511437 39511437 C T exon6 : c.754G>A ; p.A252T 4.07E-06 D D D D 7.167 
4 39501810 39501810 G A exon12 : c.1438C>T ; p.P480S 4.07E-06 D P D D 8.27 
4 39512468 39512468 G C exon4 : c.278C>G ; p.T93R 4.07E-06 D D D D 9.137 
4 39512477 39512477 T C exon4 : c.269A>G ; p.N90S 4.07E-06 D D D D 7.424 
4 39512477 39512477 T G exon4 : c.269A>C ; p.N90T 4.07E-06 D D D D 7.424 
4 39505545 39505545 G A exon11 : c.1324C>T ; p.R442W 4.06E-06 D D D D 4.839 
4 39505566 39505566 G C exon11 : c.1303C>G ; p.P435A 4.06E-06 D D D D 9.768 
4 39512004 39512004 G T exon5 : c.632C>A ; p.T211N 4.06E-06 D D D D 9.196 
4 39512014 39512014 T A exon5 : c.622A>T ; p.I208F 4.06E-06 D D D D 7.47 
4 39512158 39512158 G A exon5 : c.478C>T ; p.P160S 4.06E-06 D D D D 9.137 
4 39512414 39512414 G A exon4 : c.332C>T ; p.A111V 4.06E-06 D P D D 9.137 
4 39512052 39512052 A G exon5 : c.584T>C ; p.L195P 4.06E-06 D D D D 8.697 
4 39512109 39512109 T C exon5 : c.527A>G ; p.D176G 4.06E-06 D D D D 7.47 
4 39512113 39512113 G T exon5 : c.523C>A ; p.P175T 4.06E-06 D D D D 9.196 
4 39512136 39512136 G A exon5 : c.500C>T ; p.T167I 4.06E-06 D D D D 9.137 
4 39512145 39512145 G T exon5 : c.491C>A ; p.A164E 4.06E-06 D D D D 9.137 
4 39512345 39512345 A C exon4 : c.401T>G ; p.V134G 4.06E-06 D D D D 8.642 
4 39512345 39512345 A G exon4 : c.401T>C ; p.V134A 4.06E-06 D P D D 8.642 
4 39512351 39512351 A C exon4 : c.395T>G ; p.V132G 4.06E-06 D D D D 8.642 
4 39512367 39512367 T G exon4 : c.379A>C ; p.T127P 4.06E-06 D P D D 5.693 
4 39512376 39512376 T C exon4 : c.370A>G ; p.K124E 4.06E-06 D D D D 7.424 
          Total =  4.06E-04           
 
Supplementary Table 7: Additional potentially pathogenic missense variants from gnomAD. Abbreviations: Chr = chromosome, 
Ref = reference, Alt = alternative; n/a: not applicable; D = damaging (SIFT) / probably damaging (Polyphen2) / deleterious (LRT) / disease 
causing (Mutation Taster); P = possibly damaging. All cDNA positions refer to transcript NM_003359. Annotations were obtained using 
ANNOVAR6. 
 





Column1 total MAF in gnomAD estimated prevalence 1 patient per 
identified mutations 1.84E-04     
additional LoF 8.32E-05     
additional potentially pathogenic missense variants 4.06E-04     
total 6.73E-04 4.53E-07 2.21E+06 
total without potentially pathogenic missense variants 2.68E-04 7.16E-08 1.40E+07 
 
Supplementary Table 8: Prevalence estimation based on gnomAD. Abbreviation: MAF: minor allele frequency. 
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